Italy
· Delayed Price · Currency is EUR Blueprint Medicines Statistics
Total Valuation
BIT:1BPMC has a market cap or net worth of EUR 5.83 billion. The enterprise value is 5.66 billion.
| Market Cap | 5.83B |
| Enterprise Value | 5.66B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 64.58M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.21% |
| Shares Change (QoQ) | +4.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 63.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.20 |
| PB Ratio | 18.40 |
| P/TBV Ratio | 18.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -39.27 |
| EV / Sales | 11.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -40.53 |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 2.08.
| Current Ratio | 2.80 |
| Quick Ratio | 2.62 |
| Debt / Equity | 2.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.73 |
| Interest Coverage | -2.44 |
Financial Efficiency
Return on equity (ROE) is -47.71% and return on invested capital (ROIC) is -11.09%.
| Return on Equity (ROE) | -47.71% |
| Return on Assets (ROA) | -9.75% |
| Return on Invested Capital (ROIC) | -11.09% |
| Return on Capital Employed (ROCE) | -18.44% |
| Revenue Per Employee | 759,233 |
| Profits Per Employee | -210,336 |
| Employee Count | 649 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, BIT:1BPMC had revenue of EUR 520.07 million and -144.08 million in losses. Loss per share was -2.27.
| Revenue | 520.07M |
| Gross Profit | 501.78M |
| Operating Income | -161.27M |
| Pretax Income | -142.38M |
| Net Income | -144.08M |
| EBITDA | -146.52M |
| EBIT | -161.27M |
| Loss Per Share | -2.27 |
Balance Sheet
The company has 533.13 million in cash and 659.97 million in debt, giving a net cash position of 172.51 million.
| Cash & Cash Equivalents | 533.13M |
| Total Debt | 659.97M |
| Net Cash | 172.51M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 316.54M |
| Book Value Per Share | 4.90 |
| Working Capital | 417.71M |
Cash Flow
In the last 12 months, operating cash flow was -134.66 million and capital expenditures -4.96 million, giving a free cash flow of -139.62 million.
| Operating Cash Flow | -134.66M |
| Capital Expenditures | -4.96M |
| Free Cash Flow | -139.62M |
| FCF Per Share | n/a |
Margins
Gross margin is 96.48%, with operating and profit margins of -31.01% and -27.70%.
| Gross Margin | 96.48% |
| Operating Margin | -31.01% |
| Pretax Margin | -27.38% |
| Profit Margin | -27.70% |
| EBITDA Margin | -28.17% |
| EBIT Margin | -31.01% |
| FCF Margin | n/a |
Dividends & Yields
BIT:1BPMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.21% |
| Shareholder Yield | -4.21% |
| Earnings Yield | -2.47% |
| FCF Yield | -2.40% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1BPMC has an Altman Z-Score of 1.93. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | n/a |